ライフサイエンスコーパス: option

1 ect (the posterior probability of the chosen option).

2 e TLR8 agonist may be an effective treatment option.

3 lity that immune modulation is a therapeutic option.

4 ccepting OIT, respectively, as a therapeutic option.

5 molecular mechanisms seeding evolutionary co-option.

6 ing value independent of the identity of the option.

7 with surgical valves, SAVR was the preferred option.

8 nalization and cysteic acid decarboxylase co-option.

9 modulation was rationalized as a therapeutic option.

10 ning behavior or persuasion-there is another option.

11 l may turn out to be the preferred treatment option.

12 ement is suggested, with surgery as the last option.

13 us are not suitable as a long-term treatment option.

14 ion, or debulking, as an effective treatment option.

15 transplantation represents the only curative option.

16 g more information about a smaller number of options.

17 ble new preventive and therapeutic treatment options.

18 ratify patients and selection of therapeutic options.

19 th high 5-year mortality and few therapeutic options.

20 a and their evolution, and reviews treatment options.

21 HER2-targeted agents have limited treatment options.

22 ate the climate benefits of these management options.

23 ine the merits and disadvantages of possible options.

24 prevention measures, and effective treatment options.

25 other option than individuals naive to both options.

26 n when evaluating secondary intraocular lens options.

27 should be considered with regard to therapy options.

28 ave begun to explore alternative therapeutic options.

29 ty, variable efficacy, and unsuitable dosing options.

30 ntation have poor outcomes and few treatment options.

31 rivers of the disease and possible treatment options.

32 PrP), and there are currently no therapeutic options.

33 ) has a poor prognosis and limited treatment options.

34 imal control to examine several intervention options.

35 ms of breast cancer with limited therapeutic options.

36 veness within the different simulated dosage options.

37 ce-based data are needed to inform treatment options.

38 s with known values and exploring unfamiliar options.

39 ing tailored patient antimicrobial treatment options.

40 rialized countries and has limited treatment options.

41 the consideration of all possible management options.

42 linical trials to provide expanded treatment options.

43 our understanding of AF and some therapeutic options.

44 ing oncological and reconstructive treatment options.

45 th uncertain prognosis and limited treatment options.

46 endometrial carcinoma have limited treatment options.

47 rvival (OS) and no approved systemic therapy options.

48 e, stability, and affordability of synthetic options.

49 y were better than other currently available options.

50 uires judgments of the relative value of the options, a process necessary for species survival.

51 e posterior probability of the chosen (best) option alone, or by the overall uncertainty (entropy) of

52 ing composting to be a feasible waste stream option and a sustainable marketing edge while treading t

53 is being explored as an alternative therapy option and is based upon antibody-opioid sequestering to

54 adventure in choosing between the myriad of options and considerations present when deciding what pe

55 riety of interactive and customizable search options and data browsing functions; these capabilities

56 increases, along with improving therapeutic options and more aggressive treatment of elderly patient

57 at an advanced stage, which limits surgical options and portends a dismal prognosis.

58 bership survey includes five outmoded ethnic options and postmeeting surveys that are not designed to

59 iscussions, we explore several data analysis options and the optimum design that balances practical c

60 alongside potential alternative therapeutic options and their limitations.

61 to investigate interventions to expand donor options and to prevent ART interruptions for patients wi

62 t parts of the decision space defined by the options' and the distractor's values.

63 en in Phase III trials of other pangenotypic options, and has been conducted at a similar scale in a

64 he United States, lacks targeted therapeutic options, and is associated with a 40-80% risk of recurre

65 ysiology, percutaneous therapeutic treatment options, and ongoing clinical trials for functional mitr

66 advances in medical technology, health care options, and population health interventions.

67 n breadth-spreading our capacity across many options-and depth-gaining more information about a small

68 which drug to use among several therapeutic options; and (3) increasing awareness of how to anticipa

69 Additional options are atezolizumab/carboplatin/nab-paclitaxel, ate

70 Effective options are available for patients who may be pregnant,

71 mal specimen types for each test?" and "What options are available for T. pallidum molecular epidemio

72 A wide range of multifocal IOLs options are available on the market to surgeons.

73 Currently, no treatment options are available to establish remyelination.

74 er has access to how well supported unchosen options are by the sensory evidence.SIGNIFICANCE STATEME

75 at people are less confident if the best two options are closer to each other in posterior probabilit

76 ved by all patients, alternative therapeutic options are currently being evaluated.

77 pect theory introduced the notion that risky options are evaluated relative to their recent context,

78 The only available 2 treatment options are intravenous alteplase and endovascular thera

79 es remain poorly understood, and therapeutic options are limited.

80 ain metastases, a growing number of systemic options are now available and/or are under active invest

81 Several options are possible, including waiting for spontaneous

82 New therapeutic options are urgently needed, but regenerative therapies

83 Currently, the only option available to attenuate chemotherapy-induced neuro

84 for more effective treatments to bolster the options available for melanoma patients.

85 wn for its ability to escape the therapeutic options available to date thanks to the presence of a su

86 e number of molecularly stratified treatment options available to patients with colorectal cancer (CR

87 ly understood, and information and treatment options available to physicians and patients are limited

88 nt treatment of milder disease, limiting the options available to pregnant women with severe COVID-19

89 ith no specific therapeutic and prophylactic options available, the virus has infected millions of pe

90 formation-gathering capacity between several options before receiving feedback.

91 t independently learned the probabilities of options being safe and of partners being reliable and co

92 em cell transplantation is the only curative option, but a high risk of graft failure and poor immune

93 t could improve access to IUI as a treatment option by allowing satellite doctor's offices to offer i

94 Various treatment options can be used, ranging from bisphosphonates to den

95 e find that even across different technology options CLEAR matches the observed (post-diction) consta

96 These options collectively minimize the complexity of glucagon

97 to access data via keyword, ID and advanced options combination search in an efficient and user-frie

98 aking process to decide on further screening options consisting of either undergoing an immunological

99 lobal health problem, with limited treatment options currently available.

100 ults: Compared with the other reconstruction options, DDG-retro increased the SUV(max) and decreased

101 Exploration of spatially unstructured options depends on the neocortex, striatum, and amygdala

102 AgNPs) have been described as an alternative option due to their physicochemical properties.

103 ormational switch with differential response options during viral infection.

104 estration measures requires a diverse set of options, each adapted to local soil conditions and manag

105 de repeated choices between harmful and safe options, each with different probabilities of generating

106 an efficacious and well-tolerated treatment option for carbapenem-nonsusceptible infections.

107 etion of image registration is thus a viable option for cardiac motion estimation that can still have

108 -Fluorouracil (5-FU) is a standard treatment option for colorectal cancer (CRC) but its rapid metabol

109 Radioembolization is a treatment option for colorectal cancer (CRC) patients with inopera

110 may represent a novel, superior preservation option for donation after circulatory death renal grafts

111 Surgery is a widely accepted treatment option for drug-resistant focal epilepsy.

112 poor, and double-lung transplantation is an option for eligible patients.

113 ic total gastrectomy remains the recommended option for gastric cancer risk management in pathogenic

114 tatin/relebactam is an appropriate treatment option for gram-negative HABP/VABP, including in critica

115 RAC1 axis represents a promising therapeutic option for improving survival outcomes of RMS patients.

116 is a guideline-approved image-guided therapy option for liver cancer using the radiopaque drug-carrie

117 s that BADM grafts represent an implantation option for lower eyelid retraction repair.

118 provides an additional much needed treatment option for lymphoma.

119 V therapy and provides a potential treatment option for managing human SUDV infection.

120 targeting of this signaling axis as a viable option for melanoma treatment.

121 geable toxicity, being a tolerable treatment option for most patients.

122 rs (LCPs) with tunable luminescence as a new option for optical multiplexing.

123 engineered offers an attractive alternative option for passive immunization.

124 conclusion, DOACs are an effective treatment option for patients with cancer and acute VTE, although

125 Bariatric surgery may be a viable option for patients with cirrhosis and extreme obesity.

126 the potential to become a valuable treatment option for patients with NMOSD.

127 Ixekizumab offers a potential therapeutic option for patients with non-radiographic axial spondylo

128 hen stereotactic ablative radiotherapy is an option for patients with non-small cell lung cancer (NSC

129 K4/6 or EZH2 inhibitors as a new therapeutic option for patients with psoriasis.

130 stimulation (DBS) is an effective treatment option for patients with refractory obsessive-compulsive

131 This supports DBS as a viable treatment option for patients with TRD.

132 ces to offer intrauterine insemination as an option for patients without the clinical support require

133 rapy is under investigation as a therapeutic option for persons with hemophilia A.

134 zed-PAC to be an effective in situ treatment option for PFAS-impacted groundwater.

135 A or AD may be a promising early therapeutic option for prevention of Abeta accumulation in the brain

136 R/dCas9 epigenetic editing may provide a new option for promoting axon regeneration and functional re

137 Deep brain stimulation (DBS) is a treatment option for refractory chronic cluster headache (CCH).

138 ial if this technology is to become a viable option for renewable chemical and fuel production.

139 onsideration of nivolumab + ipilimumab as an option for second-line therapy and third-line therapy is

140 and therefore, might offer a novel treatment option for SIAD.

141 ment therapy (ERT) is a standard therapeutic option for some types of mucopolysaccharidoses, includin

142 th a metal halide perovskite are a promising option for surpassing the single-cell efficiency limit.

143 s of this study, data suggests GTR is a good option for the treatment of infrabony defects because it

144 Therefore, immunotherapy is the only option for the treatment of tumor dormancy.

145 Currently, the main therapeutic option for these dysfunctions is neobladder reconstructi

146 vacizumab might become a promising treatment option for these patients.

147 makes this new methodology a very appealing option for this archetypical organic reaction.

148 liver transplant has emerged as a promising option for unresectable hilar cholangiocarcinoma (hCCA).

149 ic surgery is the most effective weight loss option for Veterans with severe obesity, but fewer than

150 ewater irrigation is a prominent alternative option for water scarce countries, however prior testing

151 Gene correction presents one of few options for a cure for all patients with cystic fibrosis

152 s for drug screening and promising treatment options for a wide variety of neural diseases.

153 Treatment options for Achromobacter xylosoxidans are limited.

154 ifying selected crucial drivers and possible options for addressing the DBM at all levels.

155 imicrobials, have made alternative treatment options for AMR pathogens increasingly attractive.

156 for these purposes that provide customizable options for calculating sample- and feature-specific bac

157 lmonary embolectomy, and a growing number of options for catheter-based therapy.

158 y therapeutic results that could provide new options for cell-based therapeutics with curative intent

159 nvironment to identify potential therapeutic options for chemorefractory PDAC.

160 updated with new evidence and provides newer options for diagnosis and treatment of valvular heart di

161 updated with new evidence and provides newer options for diagnosis and treatment of valvular heart di

162 approach, which proposes further therapeutic options for each BCLC-defined stage.

163 nce of anti-EBV agents, however, therapeutic options for EBV-related diseases are limited.

164 Clinicians have limited therapeutic options for enteric as a result of increasing antimicrob

165 itivity testing all lead to different policy options for genomics.

166 erve source for acini widens the therapeutic options for hyposalivation.

167 tatin (or a lower dose) seem to be favorable options for improving statin adherence.

168 w describes the context of health equity and options for integrating equity into public health practi

169 ecoy approaches against HIV-1 are attractive options for long-term viral control, but initial designs

170 nges caused by the COVID-19 pandemic, review options for maintaining or altering best practices, and

171 Options for management include antiplatelet therapy, car

172 in men in America, and there are no curative options for metastatic castration-resistant prostate can

173 Therapeutic options for metastatic UM are limited, with clinical tri

174 nses at barrier sites and offers therapeutic options for modulating inflammatory/autoimmune disorders

175 cle-invasive bladder cancer, the therapeutic options for muscle-invasive and advanced disease has exp

176 are widely used immunotherapeutic treatment options for patients with advanced-ie, unresectable or m

177 ial for improving diagnostic and therapeutic options for patients.

178 yndrome; and the addition of newer treatment options for resteroid-refractory acute and chronic GVHD.

179 Currently there are few treatment options for SARS-CoV-2 infections.

180 gst the most commonly prescribed therapeutic options for sinonasal diseases in humans.

181 ion of the edges to the total release offers options for technical solutions which have the possibili

182 of challenging climatic conditions, limited options for the transportation of equipment and process

183 noma and who had exhausted available therapy options for their disease.

184 ch is needed to establish the best treatment options for these high-risk patients.

185 s, given the limited and expensive treatment options for these patients.

186 for the development of alternative treatment options for this devastating disease.

187 or advanced HCC and provide recommended care options for this patient population.

188 cancer, the discovery of stratified medicine options for tobacco-associated NSCLC is a high priority.

189 Current therapeutic options for treating these diseases include antiangiogen

190 We also provide three options for using this tool with ease: (1) a stand-alone

191 uch faster database searches and several new options for visualization of the structural differences

192 rivaroxaban and edoxaban have been added as options for VTE treatment; patients with brain metastase

193 arization was not a cost-effective treatment option from a payer/healthcare point of view.

194 sion strategies, in particular the mid-level option (fusion of selected variables from the different

195 understanding is incomplete, the therapeutic options have limited efficacy, and are often fraught wit

196 ive than SLIT, being the most cost-effective option (ICER for SCIT, euro 11 418; ICER for SLIT, euro

197 sis was shown to rely on skin tests as first option in almost 2/3 of all types of allergic diseases a

198 tecan may represent a novel targeted therapy option in cervical cancer patients overexpressing Trop-2

199 Nonetheless, the relative position of each option in driving responses in the population subspace i

200 from the Institute of Anatomy are a valuable option in obtaining grafts for corneal transplantation,

201 DAIR is a viable option in patients with early PJI presenting more than 4

202 ect endoscopic necrosectomy is a therapeutic option in patients with large amounts of infected necros

203 Single-agent pembrolizumab is an option in select cases of low positive PD-L1.

204 icrobiota transplantation may be a treatment option in sepsis associated with immunosuppression.

205 lishes tipifarnib as a potential therapeutic option in T-cell leukemia and TCL.

206 This may represent a suitable therapeutic option in the absence of any other therapeutic approache

207 , rendering pazopanib a putative therapeutic option in the first-line treatment of STS in patients ag

208 rposing is potentially the fastest available option in the race to identify safe and efficacious drug

209 pe-2 receptor (CB2R) can represent a helpful option in the treatment of OA.

210 bozantinib could represent a new therapeutic option in this setting, and deserves further investigati

211 further investigation as a chemotherapy-free option in this setting.

212 bed developmental myelination is a promising option in treating diffuse white matter injury, previous

213 ng trade-offs between demand and supply-side options in climate stabilization scenarios.

214 rofluidics thus offers attractive automation options in diagnostic settings.

215 entify promising sustainable intensification options in high-yielding cereal systems.

216 proaches that might provide future treatment options in the secondary prevention of cardioembolic str

217 ied by the relative directness to the chosen option, in a domain for which conflict is integral: deci

218 Conservative treatment options include brachytherapy, local resection and/or cr

219 These options include cognitive behavioural therapy, heat ther

220 Therapeutic options include symptomatic strategies only and are unsa

221 tential effectiveness of different treatment options including a top load (low volume) and exchange (

222 herapy (OIT) as a promising, novel treatment option, including that for the now Food and Drug Adminis

223 Treatment options, including immune modulation and combination imm

224 We evaluated several implementation options, including varying coverage levels; staggered in

225 the long-term impact of physiologic surgical options, including vascularized lymph node transplant (V

226 After having learnt one option, individuals are 31x more likely to subsequently

227 Despite the availability of new treatment options, initial systemic regimens for solid tumors are

228 entives and policies to translate management options into region- and soil-specific practices.

229 An additional treatment option is pembrolizumab/carboplatin/(paclitaxel or nab-p

230 introduction of several effective treatment options, it is now even more important to detect and mon

231 no consensus on management, and therapeutic options may be further limited by patient and physician

232 ession and widen the spectrum of therapeutic options.METHODSWe performed a flow cytometric characteri

233 art failure and despite advanced therapeutic options, morbidity and mortality rates remain high.

234 als and switched their gaze between response options more frequently during inaccurate trials and acc

235 Despite the approved treatment options nintedanib and pirfenidone, the medical need for

236 ults are unchanged with the exception of the option of adding olanzapine in the setting of hematopoie

237 cestral polymorphism resulting from early co-option of dsx as a mimicry locus, and that evolutionary

238 zymes acting on lignin and cellulose, (2) co-option of genes present in saprotrophic ancestors to ful

239 table toxicity or to stop nivolumab with the option of on-study retreatment after disease progression

240 signed (in a 3:1 ratio) patients who had the option of using at least one fully active, approved anti

241 d or refractory DLBCL who had no therapeutic options of potential clinical benefit.

242 sing additional dimensions and interactivity options offered through VR, we provide a new, interactiv

243 mastectomy are currently the only effective options offered to women with high-risk germline mutatio

244 In natural environments, however, better options often cluster together, forming structured value

245 ture on the body wall resulting from gene co-option, or evolved from an exite (outgrowth; for example

246 ent-experienced have limited or no treatment options, owing to multidrug resistance(6).

247 stic modality is a desirable, cost-effective option, potentially providing rapid readout in minutes f

248 l aortic atresia and limited dialysis access options presented to our institution for consideration o

249 of epilepsy in adults, but current treatment options provide limited efficacy, leaving as many as one

250 probabilities of the best and the next-best options, rather than by the posterior probability of the

251 tuberculosis (DR-TB) and limited therapeutic options, referred from other healthcare institutions, si

252 ent of this disease, and effective treatment options remain very limited.

253 based responses to favorable and unfavorable options requires judgments of the relative value of the

254 h almost all other systemic cancer treatment options, RPT has shown efficacy with minimal toxicity.

255 superiority of expensive versus less costly options, substantial opportunity exists to improve the v

256 ding clinicians to explore other therapeutic options such as electroconvulsive therapy, transcranial

257 ly to subsequently asocially learn the other option than individuals naive to both options.

258 roved as a noninferior and potentially safer option than tenofovir disoproxil fumarate-emtricitabine

259 clinical setting to identify more treatment options than sequencing alone.

260 R signalling represents a viable therapeutic option that combines prevention of tertiary lymphoid str

261 oyment offers a minimally invasive treatment option that eliminates many of the risks associated with

262 rategy in these tasks is to choose the first option that is above a threshold that depends on the cur

263 mostatic powders are a noncontact endoscopic option that may be considered in cases of massive bleedi

264 l disease pathogenesis may lead to treatment options that address individual biological variations an

265 Considering the limited prophylactic options that are currently offered to women with high-ri

266 offers several visualization and comparison options that are designed to assist in novel hypothesis

267 ionalities and offer a variety of structural options that can be altered to fit a specific purpose.

268 ganism or individual must choose between two options that have the same expected reward but differ in

269 ts may provide novel insights into treatment options that potentially compromise the ability of patho

270 terature reviews, and analyses of regulatory options, the Collaborative makes recommendations across

271 ts, they also commonly deliberate over their options, thinking through potential outcomes and reflect

272 ven the current lack of third-line treatment options, this approach warrants consideration in the cli

273 P1A pathway, may be a novel and preferential option to ameliorate alpha-syn-induced neurodegeneration

274 The user has the option to calculate centrality metrics on the nodes incl

275 One unexplored option to improve the predictive quality is to design co

276 used BKMR's hierarchical variable selection option to inform biomarker selection for Mn, Cu, and Cr.

277 ecified cognitive offloading opportunity: an option to mark the target locations with tokens during t

278 ther health care providers at high risk, the option to opt out of the care Covid-19 suspected or infe

279 and gene therapy is an attractive treatment option to prevent vision loss.

280 This technique may allow an additional option to providers to remove complex, large mucosal-bas

281 was then accepted as a viable "alternative" option to the subcutaneous route.

282 The only available option to treat radiation-induced hematopoietic syndrome

283 vides a potential nervous-system-independent option to treat spasticity and muscle stiffness.

284 exciting results; however, there are limited options to characterize reactions in crystallo in advanc

285 Currently, there are no approved treatment options to control WNV infection.

286 n a century of intense research, therapeutic options to halt or reverse renal disease are rather limi

287 esearch may offer several advantages and new options to help control the disease.

288 cedures employed here, but there are several options to improve it to give comparable/better performa

289 With this FTIR method we expand current options to investigate the interfacial behavior of food

290 erbicide tolerant crops provided growers new options to manage weeds, the widespread adoption of thes

291 select among a growing list of gene therapy options to maximize safety and efficacy while minimizing

292 at clinicians consider alternative treatment options to off-label gabapentin for the management of ch

293 ent this evolving armamentarium of treatment options, to elucidate mechanisms of resistance, and to c

294 vailable, will you get vaccinated?" Response options were "yes," "no," and "not sure." Participants w

295 or whom no other satisfactory reconstructive options were available.

296 based on clinical observations and treatment options were confined to application of corticosteroids

297 The values of the novel options were unknown, and the monkeys had to explore the

298 avirus infection and the related therapeutic options will be presented.

299 o the problem of choosing between exploiting options with known values and exploring unfamiliar optio

300 made more exploratory decisions (i.e., chose options without the highest expected reward value) and e